logo
16:01 Dec 05

Venmax Drugs & Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
29.63
+0.63 (+2.17%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Venmax Drugs & Pharmaceuticals Ltd. Financials

Venmax Drugs & Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
29.63
+0.63 (+2.17%)
16:01 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

33/100
Mid Valuation

Technical

54/100
Technically Neutral

Strength

11

Weakness

5

Opportunity

0

Threats

0

-0.23 %

ROE %

-0.20 %

ROA %

0.00

EPS

8.42

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
0 0 0 0.81 1.91
Operating Expenses +
0.13 0.18 0.1 1.86 2.92
Raw Material
0 0 0 0.85 1.87
Increase Decrease in Cost
0 0 0 -0.06 -0.09
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
0.01 0.03 0.02 0.04 0.09
Miscellaneous Expenses
0.12 0.15 0.08 2.73 1.05
Operating Profit
-0.13 -0.18 -0.1 -1.05 -1.01
Other Income
1.98 0.42 0.2 1.05 1.02
Depreciation
0.01 0.01 0.01 0.01 0
Interest
0 0 0 0 0
Profit before tax and exceptio..
1.85 0.23 0.09 -0.01 0.01
Exceptional Items
0 0 0 0 0
PBT
1.85 0.23 0.09 -0.01 0.01
Provision for Taxation
0 0 0.02 0 0
Net Profit
1.85 0.23 0.06 -0.01 0.02
NET Profit after MI
0 0 0 0 0
EPS
3.52 0.43 0.12 -0.02 0.02
Operating Profit Margin (%)
0 0 0 -129.63 -52.88
Net Profit Margin (%)
0 0 0 -1.23 1.05

Venmax Drugs & Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 23.10 23.10 23.10 23.10 23.10 23.10
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.20 0.20 0.20 0.20
Others 76.90 76.90 76.70 76.70 76.70 76.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: